press-release

Commitment Letter

We envision a future where no one dies prematurely from a treatable, preventable disease and all people living with or at risk of non-communicable diseases (NCDs) have access to appropriate, quality, and affordable prevention, treatments and care.

ACTION ON FISTULA TO TRANSFORM 4,500 LIVES BY 2020

Action on Fistula, supported by a grant from an affiliate of Astellas Pharma Inc., Astellas Pharma Europe Ltd. (with Astellas Pharma Inc. correctively referred to as "Astellas"), is a programme set up by the Fistula Foundation in 2014 to transform the lives of more than 1,200 women in Kenya.

22 Biopharma Companies Partner and Launch First-of-its-kind Global Initiative to Address Rise of Non-Communicable Diseases

At the 2017 World Economic Forum in Davos, Switzerland, twenty-two leading biopharmaceutical companies launched Access Accelerated, a global initiative to advance access to non-communicable disease (NCD) prevention and care in low and middle income countries.

articles

Lettre d’Engagement

Nous envisageons un futur ou personne ne meurt prématurément d’une maladie traitable et évitable, et où tous ceux souffrant déjà ou à risque de contracter une maladie non transmissible (MNT) ont accès à une prévention, des traitements et des soins appropriés, de qualité et abordables.

Verpflichtungszusage

Wir stellen uns eine Zukunft vor, in der niemand vorzeitig an einer behandelbaren, vermeidbaren Erkrankung sterben muss.

誓約書

私たちは、治療も予防も可能な疾患によって早期に死亡する人がなく、非感染性疾患を患っている人やそのリスクを抱えるすべての人々が、適切で品質が高く、また負担可能な費用で予防や治療、ケアを利用できる未来の実現を心に描いています。

video

Possibilities

We believe a life not defined by disease is a life of possibility.